NASDAQ · CBLL
CeriBell, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CBLL: Nov 03, 2026
CeriBell, Inc. Common Stock is expected to report earnings on 11/03/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.5. The reported EPS for the same quarter last year was $-0.37.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.50 | $-0.45 | $-0.55 | 4 |
| Dec 2026 | $-0.41 | $-0.39 | $-0.43 | 3 |
| Mar 2027 | $-0.43 | $-0.40 | $-0.46 | 2 |
| Jun 2027 | $-0.43 | $-0.37 | $-0.48 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
BNK Invest · RTTNews · MarketBeat · The Motley Fool- BNK Invest · Oct 12, 12:21 PM EDTMonday's ETF Movers: IHI, REMXIn trading on Monday, the iShares U.S. Medical Devices ETF is outperforming other ETFs, up about 1.6% on the day. Components of that ETF showing particular strength include shares of Procept Biorobotics, up about 6.5% and shares of Ceribell, up about 4.1% on the day. And under
- RTTNews · Oct 2, 12:13 PM EDTWeekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data(RTTNews) – The week brought a fresh round of developments across the biotech and pharma landscape, with companies advancing new therapies through regulatory milestones, clinical studies, strategic deals and corporate activity. Key updates spanned oncology, rare diseases, cardiov
- RTTNews · Sep 30, 8:55 AM EDTCeribell Gains FDA Clearance For New EEG Monitoring Software(RTTNews) – CeriBell, Inc. (CBLL) said the FDA has cleared new software for its Ceribell System designed to simplify the interpretation of brain activity and help clinicians monitor patients more efficiently at the bedside.
- RTTNews · Sep 17, 4:10 AM EDTBiotech Stocks At 52-Week Highs – BLSM +18% On Positive Trial Data, ADPT, ILMN, CBLL, NEOG(RTTNews) – The following biotech stocks reached a 52-week high on September 16, 2026, driven by positive results from clinical trials or an upcoming conference participation.
- RTTNews · Aug 15, 2:59 AM EDTWeekly Buzz: LNTH, CBLL Win FDA Nod; AURA Cuts Jobs; TDY Buys VREX; CGEM, DFTX Meet Trial Goals(RTTNews) – This week's global biopharma sector roundup captured a mix of regulatory wins, restructuring activities, deals that expanded company pipelines, and clinical trial readouts.
- MarketBeat · Aug 12, 11:04 AM EDTCeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric PushCeriBell (NASDAQ:CBLL) outlined its plans to expand its brainwave-monitoring platform beyond seizure detection, pointing to new products for delirium, pediatric patients and eventually stroke as it continues to build its hospital customer base. Speaking at Canaccord’s 46th Annua
- The Motley Fool · Aug 10, 9:43 PM EDTCeriBell (CBLL) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 10, 7:00 PM EDTHere's What Key Metrics Tell Us About CeriBell, Inc. (CBLL) Q2 EarningsAlthough the revenue and EPS for CeriBell, Inc. (CBLL) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- MarketBeat · Aug 10, 6:04 PM EDTCeriBell Q2 Earnings Call HighlightsCeriBell (NASDAQ:CBLL) reported second-quarter 2026 revenue growth of 33% as increased utilization at existing hospital accounts and continued customer additions supported results. The company also raised its full-year revenue outlook and outlined plans to commercially launch its
- Zacks · Aug 10, 5:55 PM EDTCeriBell, Inc. (CBLL) Reports Q2 Loss, Tops Revenue EstimatesCeriBell, Inc. (CBLL) delivered earnings and revenue surprises of -13.33% and +3.22%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Aug 10, 7:47 AM EDTCeribell Secures FDA Clearance For Advanced EEG AI Enhancements(RTTNews) – Ceribell, Inc. (CBLL) announced that the U.S. FDA has granted 510(k) clearance for two new artificial intelligence algorithm enhancements integrated into its cloud-based Neurology Portal: Epileptiform Abnormality Detection and Artifact Reduction.
- Zacks · Aug 6, 5:20 PM EDTQuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue EstimatesQuidelOrtho (QDEL) delivered earnings and revenue surprises of +425.00% and +2.65%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for CeriBell, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.